Related Experiment Videos
Proarrhythmic effects of antiarrhythmic drugs: evolving concepts
1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
American Heart Journal
|April 1, 1992
Summary
Antiarrhythmic drugs can paradoxically worsen arrhythmias, a dangerous effect called proarrhythmia. Predicting this risk involves considering drug class, arrhythmia type, and patient heart function to ensure safe treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Antiarrhythmic drugs are intended to treat arrhythmias.
- These drugs can paradoxically cause or worsen arrhythmias, a phenomenon termed proarrhythmia.
Purpose of the Study:
- To highlight the paradoxical proarrhythmic effects of antiarrhythmic drugs.
- To outline factors influencing the prediction and severity of drug-induced proarrhythmia.
Main Methods:
- Review of antiarrhythmic drug effects.
- Analysis of proarrhythmic event timing (early vs. late).
- Identification of key predictors for proarrhythmic risk.
Main Results:
- Proarrhythmia can manifest early (within 30 days) or late (sudden cardiac death risk).
- Predicting proarrhythmia severity depends on drug class, arrhythmia type, and left ventricular dysfunction.
- Quantifying proarrhythmic risk is crucial before initiating therapy.
Conclusions:
- Physicians must assess proarrhythmic risk before prescribing antiarrhythmic drugs.
- Understanding risk factors allows for better benefit/risk determination.
- Proarrhythmia necessitates careful patient selection and monitoring during antiarrhythmic therapy.